Data as of Sep 30
| -0.0088 / -2.67%|
The 2 analysts offering 12-month price forecasts for Elite Pharmaceuticals Inc have a median target of 4.25, with a high estimate of 4.50 and a low estimate of 4.00. The median estimate represents a +1,223.16% increase from the last price of 0.32.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.